The predictive value and potential mechanisms of miRNA-328 and miRNA-378 for brain metastases in operable and advanced non-small-cell lung cancer
Japanese Journal of Clinical Oncology · 01.05.2015 · 45 (5) · 464-473
DOI: 10.1093/jjco/hyv009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Japanese Journal of Clinical Oncology, online erschienen am 02.02.2015. Verfasst von Dianshui Sun und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center, The Second Hospital of Shandong University, Jinan. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: The incidence of brain metastases greatly varies in patients with non-small-cell lung cancer, and molecular markers are considered to predict brain metastases. Therefore, this study sought to identify the predictive value and potential mechanisms of miRNA-328 and miRNA-378 for brain metastases in non-small-cell lung cancer. METHODS: Patients who received a curable surgery for their lung cancer were screened according to our criteria. Formalin-fixed paraffin-embedded samples from the patients were examined for the expression of miRNA-328 and miRNA-378 using real-time polymerase chain reaction and the expression of N-cadherin, E-cadherin, vascular endothelial growth factor, protein kinase Cα and S100B were investigated using immunohistochemical staining. RESULTS: In total, 86 patients were screened for this study and 23 patients were diagnosed with brain metastases during the follow-up period. Comparing patients with and without brain metastases, the expression of miRNA-328 and miRNA-378 in tumor tissues were significantly different (P = 6.2 × 10(-5) and P = 2.8 × 10(-5), respectively). For the patients with brain metastases, the expression of miRNA-328 and miRNA-378 in tumor tissues compared with para-carcinoma tissues were also significantly different (P = 2.2 × 10(-5) and P = 1.6 × 10(-5), respectively). For patients with brain metastases, the association between miRNA-328 and protein kinase Cα was significant (r = 0.591, P = 0.003), but that between miRNA-378 and protein kinase Cα was not significant (r = 0.259, P = 0.232). CONCLUSIONS: The expression of miRNA-328 and miRNA-378 in tumor tissues can be used to predict brain metastases in patients with non-small-cell lung cancer. miRNA-328 might promote brain metastases by regulating the expression of protein kinase Cα. However, the mechanisms of miRNA-378 to promote brain metastases should be studied in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Center, The Second Hospital of Shandong University, Jinan.
- Medical Department, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan.
- Pathology Department, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan.
- Department of Thoracic Surgery, Shandong Institute for Cancer Research, Jinan, China.
- Cancer Center, The Second Hospital of Shandong University, Jinan xm_sduniversity@163.com.
Zitieren
APA
Sun, D., Li, X., Ma, M., Liu, J., Xu, Y., Ye, L., Hou, H., Wang, C., Li, X., & Jiang, Y. (2015). The predictive value and potential mechanisms of miRNA-328 and miRNA-378 for brain metastases in operable and advanced non-small-cell lung cancer. Japanese Journal of Clinical Oncology, 45(5), 464-473. https://doi.org/10.1093/jjco/hyv009
Vancouver
Sun D, Li X, Ma M, Liu J, Xu Y, Ye L, et al. The predictive value and potential mechanisms of miRNA-328 and miRNA-378 for brain metastases in operable and advanced non-small-cell lung cancer. Japanese Journal of Clinical Oncology. 2015;45(5):464-473. doi:10.1093/jjco/hyv009
BibTeX
@article{Sun2015,
author = {Sun, Dianshui and Li, Xin and Ma, Maoqiang and Liu, Jie and Xu, Ying and Ye, Lan and Hou, Huaying and Wang, Cuihong and Li, Xiaomei and Jiang, Yuhua},
title = {The predictive value and potential mechanisms of miRNA-328 and miRNA-378 for brain metastases in operable and advanced non-small-cell lung cancer},
journal = {Japanese Journal of Clinical Oncology},
year = {2015},
volume = {45},
number = {5},
pages = {464--473},
doi = {10.1093/jjco/hyv009}
}
EUVIMED